We are live on ! Find out more
BAMCO Inc

BAMCO Inc Portfolio holdings

AUM $66.6B
1-Year Est. Return 7.35%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+7.35%
3 Year Est. Return
+62.2%
5 Year Est. Return
+84.27%
10 Year Est. Return
+776.55%
AUM
$43.7B
AUM Growth
+$3.11B
Cap. Flow
-$62M
Cap. Flow %
-0.14%
Top 10 Hldgs %
33.5%
Holding
434
New
40
Increased
163
Reduced
126
Closed
33

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$129M
2
ZY
Zymergen Inc. Common Stock
ZY
+$105M
3
JBGS
JBG SMITH
JBGS
+$51.7M
4
AVLR
Avalara, Inc.
AVLR
+$45.6M
5
SPOT icon
Spotify
SPOT
+$44.6M

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$118M
2
OPEN icon
Opendoor
OPEN
+$101M
3
PAGS icon
PagSeguro Digital
PAGS
+$79M
4
PENN icon
PENN Entertainment
PENN
+$70.6M
5
WIX icon
WIX.com
WIX
+$59.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.51%
2 Technology 21.41%
3 Healthcare 16.1%
4 Financials 14.22%
5 Real Estate 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYH icon
401
Community Health Systems
CYH
$416M
$2K ﹤0.01%
100
– –
AFRM icon
402
Affirm
AFRM
$24.8B
– –
-401
Closed -$28K
AMWL icon
403
American Well
AMWL
$236M
– –
-39,222
Closed -$13.6M
CMRC
404
Commerce.com Inc Series 1
CMRC
$302M
– –
-134,036
Closed -$7.75M
BIP icon
405
Brookfield Infrastructure Partners
BIP
$16.4B
– –
-46,788
Closed -$1.66M
BMBL icon
406
Bumble
BMBL
$392M
– –
-300,077
Closed -$18.7M
EBS icon
407
Emergent Biosolutions
EBS
$327M
– –
-225,000
Closed -$20.9M
EDU icon
408
New Oriental
EDU
$9.04B
– –
-271,740
Closed -$38M
ESPR
409
DELISTED
Esperion Therapeutics
ESPR
– –
-373,500
Closed -$10.5M
FOXF icon
410
Fox Factory Holding Corp
FOXF
$823M
– –
-100,000
Closed -$12.7M
GDRX icon
411
GoodRx Holdings
GDRX
$1.21B
– –
-28,676
Closed -$1.12M
HCA icon
412
HCA Healthcare
HCA
$92.1B
– –
-9,000
Closed -$1.7M
HLT icon
413
Hilton Worldwide
HLT
$69.9B
– –
-95,543
Closed -$11.6M
OLO
414
DELISTED
Olo Inc
OLO
– –
-5,000
Closed -$132K
PACB icon
415
Pacific Biosciences
PACB
$420M
– –
-385,786
Closed -$12.9M
PRPL icon
416
Purple Innovation
PRPL
$13.8M
– –
-33,488
Closed -$26.5M
PTCT icon
417
PTC Therapeutics
PTCT
$5.55B
– –
-708,697
Closed -$33.6M
SHW icon
418
Sherwin-Williams
SHW
$78.8B
– –
-34,206
Closed -$8.41M
SPCE icon
419
Virgin Galactic
SPCE
$458M
– –
-7,500
Closed -$4.59M
TME icon
420
Tencent Music
TME
$13.2B
– –
-238,462
Closed -$19M
VRM icon
421
Vroom Inc
VRM
$54.9M
– –
-2,730
Closed -$8.52M
VRTX icon
422
Vertex Pharmaceuticals
VRTX
$132B
– –
-60,113
Closed -$12.9M
ZTO icon
423
ZTO Express
ZTO
$15.8B
– –
-1,860,104
Closed -$54.2M
CPAY icon
424
Corpay
CPAY
$27.1B
– –
-180
Closed -$48K
MTEM
425
DELISTED
Molecular Templates, Inc.
MTEM
– –
-3,000
Closed -$568K
14 15 16
17
18

Similar funds

NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $67.9B AUM 39.2% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

BAMCO Inc's Q2 2021 Portfolio in Review

As of Q2 2021, BAMCO Inc held 434 positions worth $43.7B, up 7.7% from $40.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

BAMCO Inc's Q2 2021 filing shows 40 new, 163 increased, 126 reduced and 33 closed positions. Its largest new stake was Zymergen Inc. Common Stock: 2,666,218 shares worth $107M. The largest sale was Idexx Laboratories, an estimated $118M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.

  • BAMCO Inc's largest Q2 2021 buy was Zymergen Inc. Common Stock: 2,666,218 shares worth $107M.
  • BAMCO Inc added most to RingCentral in Q2 2021, an estimated $129M increase.
  • BAMCO Inc's biggest Q2 2021 reduction was Idexx Laboratories, cutting an estimated $118M.
  • BAMCO Inc fully exited ZTO Express in Q2 2021, selling an estimated $54.2M.
  • BAMCO Inc's ten largest holdings make up 33% of its $43.7B portfolio in Q2 2021.
  • BAMCO Inc opened 40 new positions and closed 33 in Q2 2021.
  • BAMCO Inc's portfolio value rose 7.7% quarter-over-quarter to $43.7B.

Based on BAMCO Inc's 13F filing for Q2 2021, filed 13 Aug 2021.